Gene knockouts are among the most straightforward applications of genome editing technology. When CRISPR-Cas9 creates a double-strand break at a target gene, the cell's non-homologous end joining repair pathway often introduces small insertions or deletions that shift the reading frame, producing a truncated, non-functional protein. This loss-of-function approach is the workhorse of functional genomics, enabling researchers to systematically determine what each gene does by observing the consequences of its absence.
In synthetic biology and metabolic engineering, gene knockouts are used strategically to redirect metabolic flux toward desired products. By eliminating competing pathways, engineers can channel cellular resources toward the biosynthetic route of interest. Ginkgo Bioworks and other biofoundries routinely perform combinatorial knockout screens to identify gene deletions that improve production of target molecules. In mammalian cell engineering, ArsenalBio uses high-throughput CRISPR knockouts to identify and remove inhibitory genes in T cells, enhancing their anti-tumor activity for cell therapy applications.
Genome-scale knockout libraries have become essential tools for biological discovery. The GeCKO and Brunello libraries enable systematic CRISPR knockout screens across all protein-coding genes in human cells, identifying genes essential for cell survival, drug resistance, and disease mechanisms. Companies like Addgene distribute these libraries to the research community, while screening platforms from companies like Cellecta and Horizon Discovery provide turnkey solutions for functional genomic studies. These large-scale knockout approaches are transforming target identification in drug discovery and providing new insights into fundamental biology.